Related by context. Frequent words. (Click for all words.) 72 target lesion revascularization 69 LVEF 69 infarct size 68 annualized relapse 68 target vessel revascularization 68 composite endpoint 67 myocardial infarction stroke 67 coronary revascularization 67 confidence interval #.#-#.# 67 endarterectomy 66 cerebrovascular events 66 P = .# 66 stent implantation 66 myocardial infarction MI 66 mg kg dose 66 cardiovascular hospitalization 66 virologic response 66 thromboembolic events 66 XIENCE V vs. 65 mg QD 65 serum phosphorus 65 thrombotic events 65 fibrinolysis 65 virologic failure 65 thromboembolism 65 vertebral fracture 65 unfractionated heparin 65 HbA1c levels 64 nonsignificant 64 CYPHER ® Stent 64 fondaparinux 64 stent restenosis 64 noninferiority 64 abciximab 63 statistically significant p = 63 reoperation 63 TAXUS stent 63 prespecified 63 achieved statistical significance 63 estimated glomerular filtration 63 thrombolytic therapy 63 carotid intima media 63 sustained virologic response 63 placebo p 63 bivalirudin 63 placebo p = 63 restenosis 63 endophthalmitis 63 glimepiride 63 nonresponders 62 leukopenia 62 stented 62 myocardial infarctions 62 cardiac dysfunction 62 EBRT 62 colectomy 62 mg BID 62 inflammatory lesions 62 discontinuations due 62 stable angina 62 A1C levels 62 angiotensin converting enzyme inhibitors 62 chemoradiotherapy 62 serum uric acid 62 plus methotrexate 62 peginterferon alfa 2a 62 TAXUS Express 62 FOLFIRI 62 Cmax 62 pg mL 62 statistically significant p 62 Secondary endpoints 62 myocardial infarction 62 febrile neutropenia 62 % CI #.#-#.# [006] 62 mitral regurgitation 61 Secondary endpoints included 61 left ventricular dysfunction 61 plus gemcitabine 61 mineral density 61 balloon kyphoplasty 61 plus prednisone 61 STEMI patients 61 cytogenetic response 61 glycated hemoglobin 61 candesartan 61 neoadjuvant 61 cardiovascular mortality 61 TAXUS 61 glomerular filtration rate 61 active comparator 61 tumor resection 61 myocardial ischemia 61 confidence interval CI 61 systolic BP 61 creatinine clearance 61 median PFS 61 neoadjuvant therapy 61 Enoxaparin 60 Combination therapy 60 neoadjuvant chemotherapy